Assignee
DIAMEDICA INC
CA·6 granted patents·13 pending applications·26 citations·filing 2003–2025
Top patents by PatentIndex Score
19 records- 0183US9616015B2Formulations of human tissue kallikrein-1 for parenteral delivery and related methodsDIAMEDICA INC·Filed 2015·Granted Apr 11, 2017·2 cites·10 claims
- 0281US9364521B2Human tissue kallikrein 1 glycosylation isoformsDIAMEDICA INC·Filed 2015·Granted Jun 14, 2016·4 cites·16 claims
- 0378US12329805B2Dosage forms of tissue kallikrein 1DIAMEDICA INC·Filed 2023·Granted Jun 17, 2025·0 cites·18 claims
- 0477US7622447B2Use of glutathione synthesis stimulating compounds in reducing insulin resistanceDIAMEDICA INC·Filed 2003·Granted Nov 24, 2009·17 cites·13 claims
- 0576US9839678B2Human tissue kallikrein 1 glycosylation isoformsDIAMEDICA INC·Filed 2016·Granted Dec 12, 2017·2 cites·14 claims
- 0675US11857608B2Dosage forms of tissue kallikrein 1DIAMEDICA INC·Filed 2018·Granted Jan 2, 2024·1 cites·24 claims
- 0768US2025339500A1Dosage forms of tissue kallikrein 1DIAMEDICA INC·Filed 2025·Application pending·0 cites
- 0859US2017340559A1Formulations of human tissue kallikrein-1 for parenteral delivery and related methodsDIAMEDICA INC·Filed 2017·Application pending·0 cites
- 0955US2009324701A1Compositions containing (s)-bethanechol and their use in the treatment of insulin resistance, type 2 diabetes, glucose intolerance and related disordersDIAMEDICA INC·Filed 2007·Application pending·0 cites
- 1055US2023414727A1Tissue kallikrein-1 for treating chronic kidney diseaseDIAMEDICA INC·Filed 2023·Application pending·0 cites
- 1154US2013224230A1Therapeutic uses of glandular kallikreinDIAMEDICA INC·Filed 2012·Application pending·0 cites
- 1254US2010008899A1Methods of diagnosis and treatment for metabolic disordersDIAMEDICA INC·Filed 2007·Application pending·0 cites
- 1354US2007009438A1Method for diagnosing diabetes type 2 using standardized mixed meal and calculated index valuesDIAMEDICA INC·Filed 2004·Application pending·0 cites
- 1451US2011150781A1Tissue kallikrein for the treatment of parkinson's diseaseDIAMEDICA INC·Filed 2009·Application pending·0 cites
- 1550US2013280235A1Methods of diagnosis and treatment for metabolic disordersDIAMEDICA INC·Filed 2013·Application pending·0 cites
- 1649US2005119272A1Use of phosphodiesterase antagonists to treat insulin resistanceDIAMEDICA INC·Filed 2003·Application pending·0 cites
- 1748US2007238762A1Use of Antagonists of Hepatic Sympathetic Nerve ActivityDIAMEDICA INC·Filed 2004·Application pending·0 cites
- 1846US2004151785A1Method for treating insulin resistance through hepatic nitric oxideDIAMEDICA INC·Filed 2004·Application pending·0 cites
- 1939US2014017242A1Anti-bradykinin b2 receptor (bkb2r) monoclonal antibodyDIAMEDICA INC·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when DIAMEDICA INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →